British Journal of Cancer, volume 124, issue 4, pages 681-682

Correlation of anti-tumour drug resistance with epigenetic regulation

Takuma Hayashi ^{1, 2}

Ikuo Konishi ^{1, 3}

Hide authors affiliations

National Hospital Organization, Kyoto Medical Center, Kyoto, Japan |

START-program, Japan Science and Technology Agency (JST), Tokyo, Japan |

Graduate school of Medicine, Kyoto University, Kyoto, Japan |

Publication type: Journal Article

Publication date: 2020-12-03

Springer Nature

Journal: British Journal of Cancer

scimago Q1

wos Q1

SJR: 3.000

CiteScore: 15.1

Impact factor: 6.4

ISSN: 00070920, 15321827

DOI: 10.1038/s41416-020-01183-y

Copy DOI

Cancer Research

Oncology

Abstract

During treatment, the development of drug-resistant tumours remains an important challenge in cancer treatment. Epigenetic changes have been reported as one of the mechanisms for anti-tumour drug resistance. In clinical practice, a combination of epigenetic-related drugs can be considered as a future selection of cancer therapeutic drugs.

Found

	1 2
Medicina	Medicina, 2, 12.5% Medicina 2 publications, 12.5%
Cancers	Cancers, 1, 6.25% Cancers 1 publication, 6.25%
Frontiers in Nanotechnology	Frontiers in Nanotechnology, 1, 6.25% Frontiers in Nanotechnology 1 publication, 6.25%
iScience	iScience, 1, 6.25% iScience 1 publication, 6.25%
Trends in Cancer	Trends in Cancer, 1, 6.25% Trends in Cancer 1 publication, 6.25%
Current Cancer Drug Targets	Current Cancer Drug Targets, 1, 6.25% Current Cancer Drug Targets 1 publication, 6.25%
Pharmaceutics	Pharmaceutics, 1, 6.25% Pharmaceutics 1 publication, 6.25%
American Journal of Physiology - Cell Physiology	American Journal of Physiology - Cell Physiology, 1, 6.25% American Journal of Physiology - Cell Physiology 1 publication, 6.25%
Medical Oncology	Medical Oncology, 1, 6.25% Medical Oncology 1 publication, 6.25%
European Journal of Medicinal Chemistry	European Journal of Medicinal Chemistry, 1, 6.25% European Journal of Medicinal Chemistry 1 publication, 6.25%
Journal of Nanobiotechnology	Journal of Nanobiotechnology, 1, 6.25% Journal of Nanobiotechnology 1 publication, 6.25%
APL Materials	APL Materials, 1, 6.25% APL Materials 1 publication, 6.25%
	1 2

	1 2 3 4
MDPI	MDPI, 4, 25% MDPI 4 publications, 25%
Elsevier	Elsevier, 4, 25% Elsevier 4 publications, 25%
Springer Nature	Springer Nature, 2, 12.5% Springer Nature 2 publications, 12.5%
Frontiers Media S.A.	Frontiers Media S.A., 1, 6.25% Frontiers Media S.A. 1 publication, 6.25%
Bentham Science Publishers Ltd.	Bentham Science Publishers Ltd., 1, 6.25% Bentham Science Publishers Ltd. 1 publication, 6.25%
American Physiological Society	American Physiological Society, 1, 6.25% American Physiological Society 1 publication, 6.25%
IntechOpen	IntechOpen, 1, 6.25% IntechOpen 1 publication, 6.25%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 1, 6.25% Cold Spring Harbor Laboratory 1 publication, 6.25%
AIP Publishing	AIP Publishing, 1, 6.25% AIP Publishing 1 publication, 6.25%
	1 2 3 4

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST | RIS | BibTex | MLA

Found error?

Publisher

Springer Nature

Journal

British Journal of Cancer

scimago Q1

wos Q1

SJR

3.000

CiteScore

15.1

Impact factor

6.4

ISSN

00070920 (Print)

15321827 (Electronic)

Correlation of anti-tumour drug resistance with epigenetic regulation

Top-30

Journals

Publishers

Are you a researcher?